News Image

Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

Provided By GlobeNewswire

Last update: Apr 15, 2025

- Vikram Ranade, PhD, appointed as chief business officer -

- Ranjan Batra, PhD, appointed as chief scientific officer -

- Oxana Beskrovnaya, PhD, transitioning to chief innovation officer -

Read more at globenewswire.com

DYNE THERAPEUTICS INC

NASDAQ:DYN (12/22/2025, 8:00:02 PM)

After market: 20.78 0 (0%)

20.78

+0.93 (+4.69%)



Find more stocks in the Stock Screener

Follow ChartMill for more